Moore Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-60,000
| Closed | -$1.47M | – | 467 |
|
|
2024
Q2 | $1.47M | Buy |
+60,000
| New | +$1.47M | 0.03% | 255 |
|
|
2015
Q2 | – | Sell |
-20,795
| Closed | -$736K | – | 435 |
|
|
2015
Q1 | $736K | Buy |
+20,795
| New | +$736K | 0.02% | 306 |
|
|
2014
Q2 | – | Sell |
-87,902
| Closed | -$3.01M | – | 470 |
|
|
2014
Q1 | $3.01M | Sell |
87,902
-77,098
| -47% | -$2.64M | 0.06% | 188 |
|
|
2013
Q4 | $3.46M | Buy |
+165,000
| New | +$3.46M | 0.05% | 176 |
|